These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27618480)

  • 1. Stress-induced cellular responses and cell death mechanisms during inflammatory cholangiopathies.
    Sasaki M; Nakanuma Y
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):129-138. PubMed ID: 27618480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy and senescence in fibrosing cholangiopathies.
    Nakanuma Y; Sasaki M; Harada K
    J Hepatol; 2015 Apr; 62(4):934-45. PubMed ID: 25435435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.
    Trussoni CE; O'Hara SP; LaRusso NF
    Semin Immunopathol; 2022 Jul; 44(4):527-544. PubMed ID: 35178659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile Acids and Deregulated Cholangiocyte Autophagy in Primary Biliary Cholangitis.
    Sasaki M; Nakanuma Y
    Dig Dis; 2017; 35(3):210-216. PubMed ID: 28249264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role of cellular senescence in biliary injury.
    Meng L; Quezada M; Levine P; Han Y; McDaniel K; Zhou T; Lin E; Glaser S; Meng F; Francis H; Alpini G
    Am J Pathol; 2015 Mar; 185(3):602-9. PubMed ID: 25619959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets.
    Sato K; Glaser S; Kennedy L; Liangpunsakul S; Meng F; Francis H; Alpini G
    Expert Opin Ther Targets; 2019 Jun; 23(6):461-472. PubMed ID: 30990740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An impaired biliary bicarbonate umbrella may be involved in dysregulated autophagy in primary biliary cholangitis.
    Sasaki M; Sato Y; Nakanuma Y
    Lab Invest; 2018 Jun; 98(6):745-754. PubMed ID: 29540861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular senescence in the cholangiopathies.
    Bogert PS; O'Hara SP; LaRusso NF
    Curr Opin Gastroenterol; 2022 Mar; 38(2):121-127. PubMed ID: 35098933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into autoimmune cholangitis through animal models.
    Trauner M; Fickert P; Baghdasaryan A; Claudel T; Halilbasic E; Moustafa T; Wagner M; Zollner G
    Dig Dis; 2010; 28(1):99-104. PubMed ID: 20460897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of senescence-associated cell cycle regulators in the progression of biliary atresia: an immunohistochemical study.
    Sasaki M; Kuo FY; Huang CC; Swanson PE; Chen CL; Chuang JH; Yeh MM
    Histopathology; 2018 Jun; 72(7):1164-1171. PubMed ID: 29392752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of cholestasis: An update on inflammatory cholangiopathies.
    Mariotti V; Cadamuro M; Spirli C; Fiorotto R; Strazzabosco M; Fabris L
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):954-964. PubMed ID: 30398152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary innate immunity: function and modulation.
    Harada K; Nakanuma Y
    Mediators Inflamm; 2010; 2010():. PubMed ID: 20798866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
    Pollheimer MJ; Fickert P; Stieger B
    Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and biliary tract injury.
    Lu BR; Mack CL
    Curr Opin Gastroenterol; 2009 May; 25(3):260-4. PubMed ID: 19396964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies.
    Salas-Silva S; Simoni-Nieves A; Lopez-Ramirez J; Bucio L; Gómez-Quiroz LE; Gutiérrez-Ruiz MC; Roma MG
    Life Sci; 2019 Feb; 218():324-339. PubMed ID: 30610870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.
    Luo Z; Jegga AG; Bezerra JA
    Hepatology; 2018 Feb; 67(2):676-689. PubMed ID: 28865156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation.
    Portmann B; Zen Y
    Histopathology; 2012 Jan; 60(2):236-48. PubMed ID: 21668470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic role of bile acids and nuclear receptor agonists in fibrosing cholangiopathies.
    Trauner M; Halilbasic E; Kazemi-Shirazi L; Kienbacher C; Staufer K; Traussnigg S; Hofer H
    Dig Dis; 2014; 32(5):631-6. PubMed ID: 25034298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and extracellular vesicles in cholangiopathies.
    Olaizola P; Lee-Law PY; Arbelaiz A; Lapitz A; Perugorria MJ; Bujanda L; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1293-1307. PubMed ID: 28711597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.